IS5496A - Notkun útskiptra amínómetýl krómanefna til að koma í veg fyrir taugahrörnun og til að hvetja endurmyndun tauga - Google Patents

Notkun útskiptra amínómetýl krómanefna til að koma í veg fyrir taugahrörnun og til að hvetja endurmyndun tauga

Info

Publication number
IS5496A
IS5496A IS5496A IS5496A IS5496A IS 5496 A IS5496 A IS 5496A IS 5496 A IS5496 A IS 5496A IS 5496 A IS5496 A IS 5496A IS 5496 A IS5496 A IS 5496A
Authority
IS
Iceland
Prior art keywords
nerve regeneration
stimulate nerve
substituted aminomethyl
prevent neurodegeneration
chromium
Prior art date
Application number
IS5496A
Other languages
English (en)
Inventor
Fahrig Thomas
Gerlach Irene
Horv βth Ervin
Jork Reinhard
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of IS5496A publication Critical patent/IS5496A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS5496A 1997-11-24 2000-05-15 Notkun útskiptra amínómetýl krómanefna til að koma í veg fyrir taugahrörnun og til að hvetja endurmyndun tauga IS5496A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19751949A DE19751949A1 (de) 1997-11-24 1997-11-24 Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
PCT/EP1998/007197 WO1999026621A1 (de) 1997-11-24 1998-11-11 Verwendung von substituierten aminomethyl-chromanen zur verhinderung der neuronalen degeneration und zur förderung der neuronalen regeneration

Publications (1)

Publication Number Publication Date
IS5496A true IS5496A (is) 2000-05-15

Family

ID=7849618

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5496A IS5496A (is) 1997-11-24 2000-05-15 Notkun útskiptra amínómetýl krómanefna til að koma í veg fyrir taugahrörnun og til að hvetja endurmyndun tauga

Country Status (30)

Country Link
US (2) US6235774B1 (is)
EP (1) EP1051170B1 (is)
JP (1) JP2001523716A (is)
KR (1) KR20010032357A (is)
CN (1) CN1134256C (is)
AR (1) AR016973A1 (is)
AT (1) ATE206615T1 (is)
AU (1) AU745759B2 (is)
BG (1) BG64167B1 (is)
CA (1) CA2311126A1 (is)
DE (2) DE19751949A1 (is)
DK (1) DK1051170T3 (is)
ES (1) ES2164465T3 (is)
HN (1) HN1998000169A (is)
HU (1) HUP0004369A3 (is)
IL (1) IL135904A (is)
IS (1) IS5496A (is)
MY (1) MY118414A (is)
NO (1) NO20002638D0 (is)
NZ (1) NZ504656A (is)
PE (1) PE134999A1 (is)
PL (1) PL340674A1 (is)
PT (1) PT1051170E (is)
RU (1) RU2217140C2 (is)
SI (1) SI1051170T1 (is)
SV (1) SV1998000138A (is)
TR (1) TR200001471T2 (is)
TW (1) TW524690B (is)
WO (1) WO1999026621A1 (is)
ZA (1) ZA9810668B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
MXPA02009071A (es) * 2000-03-17 2003-05-23 Alcon Inc Compuestos con actividad agonista de 5-ht 1a para tratar glaucoma..
US20030207890A1 (en) 2001-02-23 2003-11-06 Collier Robert J Compounds with 5-ht1a activity useful for treating disorders of the outer retina
DE10058119A1 (de) * 2000-11-22 2002-05-23 Bayer Ag Pepinotan-Kit
SE0004455D0 (sv) * 2000-12-01 2000-12-01 Milos Pekny Method for neuron regeneration in the central nervous system
DE10101917A1 (de) * 2001-01-16 2002-07-18 Bayer Ag Verwendung von Chromanen
BR0211358A (pt) * 2001-07-26 2004-09-21 Merck Patent Gmbh Uso do composto de 2-[5-(4-fluorofenil)-3-piridilmetilaminometil]-croman o e seus sais fisiologicamente aceitáveis
KR100886185B1 (ko) * 2001-09-12 2009-02-27 메르크 파텐트 게엠베하 운동 장애의 치료 및 추체외로 운동 장애의 치료를 위해 투여된 약물에 의해 유도된 부작용의 치료를 위한 치환된 아미노메틸 크로만의 신규한 용도
DE10155075A1 (de) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclische Sulfonamide
ITTO20030140U1 (it) * 2003-09-16 2005-03-17 Interfila Srl Matita cosmetica
CA2580584C (en) * 2003-09-19 2015-07-28 Galileo Pharmaceuticals, Inc. Use of alpha-tocotrienol for treatment of mitochondrial diseases
DE102004017627A1 (de) * 2004-04-10 2005-10-27 Bayer Healthcare Ag Verwendung von vollen 5-HT1A-Agonisten zur Hemmung der opiat/opioid-induzierten Atemdepression
EA201990400A1 (ru) 2016-07-29 2019-07-31 Суновион Фармасьютикалз, Инк. Соединения и композиции и их применение
MX2019000982A (es) 2016-07-29 2019-07-04 Sunovion Pharmaceuticals Inc Compuestos y composiciones y usos de los mismos.
RU2651756C1 (ru) * 2017-05-10 2018-04-23 Федеральное государственное бюджетное образовательное учреждение Высшего Образования Кубанский Государственный Медицинский Университет Министерства Здравоохранения Российской Федерации, КубГМУ Препарат для предотвращения образования глиальных рубцов
JP7191085B2 (ja) * 2017-08-02 2022-12-16 サノビオン ファーマシューティカルズ インク イソクロマン化合物およびその使用
CN113784755B (zh) 2019-03-14 2024-05-10 赛诺维信制药公司 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5300523A (en) 1988-07-28 1994-04-05 Bayer Aktiengesellschaft Substituted aminomethyltetralins and their heterocyclic analogues
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
GB9012316D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE19522088A1 (de) 1995-06-19 1997-01-02 Bayer Ag Benzisothiazolyl-substituierte Aminomethylchromane
DE19751949A1 (de) * 1997-11-24 1999-05-27 Bayer Ag Verwendung von substituierten Aminomethyl-Chromanen zur Verhinderung der neuronalen Degeneration und zur Förderung der neuronalen Regeneration

Also Published As

Publication number Publication date
TW524690B (en) 2003-03-21
ES2164465T3 (es) 2002-02-16
KR20010032357A (ko) 2001-04-16
EP1051170A1 (de) 2000-11-15
HUP0004369A2 (hu) 2001-04-28
PT1051170E (pt) 2002-02-28
WO1999026621A1 (de) 1999-06-03
ZA9810668B (en) 1999-05-26
NO20002638L (no) 2000-05-23
DK1051170T3 (da) 2001-12-27
PE134999A1 (es) 2000-03-05
AU745759B2 (en) 2002-03-28
MY118414A (en) 2004-10-30
AU1668599A (en) 1999-06-15
CN1134256C (zh) 2004-01-14
DE19751949A1 (de) 1999-05-27
AR016973A1 (es) 2001-08-01
US6331561B2 (en) 2001-12-18
CA2311126A1 (en) 1999-06-03
BG64167B1 (bg) 2004-03-31
BG104466A (en) 2001-02-28
HN1998000169A (es) 1999-11-03
ATE206615T1 (de) 2001-10-15
EP1051170B1 (de) 2001-10-10
HUP0004369A3 (en) 2002-04-29
IL135904A0 (en) 2001-05-20
PL340674A1 (en) 2001-02-12
NZ504656A (en) 2002-02-01
TR200001471T2 (tr) 2000-10-23
IL135904A (en) 2003-07-06
CN1279604A (zh) 2001-01-10
JP2001523716A (ja) 2001-11-27
SI1051170T1 (en) 2001-12-31
RU2217140C2 (ru) 2003-11-27
NO20002638D0 (no) 2000-05-23
DE59801724D1 (de) 2001-11-15
US20010018530A1 (en) 2001-08-30
US6235774B1 (en) 2001-05-22
SV1998000138A (es) 1999-05-25

Similar Documents

Publication Publication Date Title
ATE205694T1 (de) Triacetin zur erhöhung der transdermalen penetration
IS2057B (is) Aðferðir og lyfjablöndur til að örva vöxt taugaþráða með því að nota efnasambönd sem eru næm fyrir FKBP12 í sambandi við taugavaxtarþætti
DK0925022T3 (da) Forbedringer med relation til hudprikkenåle
NO994506D0 (no) FremgangsmÕter og blandinger for Õ modulere mottagelighet for kortikosteroider
IS5006A (is) Aðferð til þess að auka sértækni í ljósörvun sameinda
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO984806D0 (no) Geleringsmiddel for hydrokarbonvµske og anvendelsesmetode
DE69822216D1 (de) Mehrteilige spritze zum manuellen auftragen von substanzen
ID20400A (id) Komposisi dan metoda untuk menghambat penuaan akibat cahaya pada kulit
IS5007A (is) Aðferð til þess að auka sértækni í ljósörvun og greiningu greiningarsameinda
DE19882672T1 (de) Sicheres Verbinden von Bauteilen mittels Federringen
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
DE69819006D1 (de) Verwendung von ginsenoside rb1 zur stimulierung der elastinsynthese
NO20002638L (no) Anvendelse av substituerte aminometylkromaner for Õ forhindre nevronal degenerasjon og for Õ fremme nevronal regenerasjon
FI971349L (fi) Asfaltin irrote ja käyttömenetelmä
IS2049B (is) Notkun amína til að framleiða lyf til að koma í veg fyrir fjölgun æxlisfrumna
ID17323A (id) Metode dan sistim untuk mensintesa oligonukleotida-oligonukleotida dengan menggunakan batang-batang bebas nukleotida-spesifik
IS4805A (is) Aðferð til meðhöndlunar og lyfjasamsetning
EP1005480A4 (en) HUMAN KINASE PROTEIN KINASES ACTIVATED BY ONCOPROTEIN, STRESS AND CYTOKINE
ATE217518T1 (de) Verwendung mindestens eines in 6-stellung substituierten pyrimidin-3-oxids zur stimulierung von tyrosinase
ID20819A (id) Semaforin l manusia (h-sema l) dan semaforin yang sesuai dalam spesies lainnya
EP1039897A4 (en) COMPOUNDS BASED ON INADONE AND TETRALONE FOR INHIBITING CELL PROLIFERATION
IS4628A (is) Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka
DE69718681D1 (de) Verfahren und mechanismus zur in situ sensibilisierung von wasserenthaltenden explosivstoffen
DE59809268D1 (de) Injektor und dessen Verwendung zum Besprühen von Katalysatorbetten